piperacillin has been researched along with cefazolin in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (8.62) | 18.7374 |
1990's | 8 (13.79) | 18.2507 |
2000's | 25 (43.10) | 29.6817 |
2010's | 14 (24.14) | 24.3611 |
2020's | 6 (10.34) | 2.80 |
Authors | Studies |
---|---|
Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Amicosante, G; Caporale, B; Celenza, G; Docquier, JD; Mezzatesta, M; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Bonnet, R; Neuwirth, C; Robin, F; Siebor, E | 1 |
Amicosante, G; Celenza, G; De Santis, F; Forcella, C; Pellegrini, C; Perilli, M; Rossolini, GM; Stefani, S | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
Bell, JM; Castanheira, M; Jones, RN; Mathai, D; Turnidge, JD | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
De Luca, F; Docquier, JD; Fosse, T; Giraud-Morin, C; Rossolini, GM | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Berry, V; Mizen, L; Woodnutt, G | 1 |
Ishii, A; Kanazawa, I; Mizusawa, H; Nagata, H; Ohkoshi, N | 1 |
Bawdon, RE; Brown, CE; Christmas, JT | 1 |
Gibson, G; Nachamkin, I; Samel, C; Sawyer, K; Skalina, D | 1 |
Barry, AL; Beskid, G; Cleeland, R; Fallat, V; Isenberg, HD; Murray, PR; Pierson, C; Squires, E; Tilton, RC | 1 |
Hayashi, T; Kitayama, R; Kumada, T; Kumano, K; Saikawa, I; Shimizu, K; Totsuka, K; Watanabe, Y; Yasuda, T | 1 |
Malottke, R; Potel, J | 1 |
Mirrett, S; Reimer, LG; Reller, LB | 1 |
Borowy, ZJ; Burul, CJ; Deitel, M; Fuksa, M; Krajden, S; Langer, JC; Rowan, J; Smith, LC; Wooster, DL; Yaman, M | 1 |
Shinagawa, N | 1 |
Fernández-Roblas, R; Gadea, I; García-Corbeira, P; Ponte, C; Soriano, F | 1 |
Bowers, JL; Cay, O; Clouse, ME; Nosaka, T | 1 |
Bailie, GR; Crawford, TL; Diaz-Buxo, JA | 1 |
Arakawa, S; Hayashi, Y; Iwai, S; Kamidono, S; Kumon, H; Matsumoto, T; Shinagawa, N; Takeyama, H; Tsukamoto, T; Yokoyama, T | 1 |
Ishizuka, Y; Iwai, S; Kawauchi, H; Kurono, Y; Oda, M; Shinagawa, N; Suzuki, K; Takeyama, H; Yajin, K; Yamanaka, N; Yokoyama, T | 1 |
Araake, M; Hara, T; Tsuruoka, T; Watabe, H | 1 |
Castillo Caparrós, A; Montijano Cabrera, AM | 1 |
Etches, W; Lee, B; Robinson, JL; Saxinger, L; Stang, L; Tawfik, G | 1 |
Akay, T; Ozkan, S | 1 |
Harada, AS; Lau, W | 1 |
Cheng, CJ; Chou, CH; Lin, CS; Lin, SH | 1 |
Adamson, RT; Amara, S; Huang, X; Lew, I | 1 |
Ito, K; Kitagawa, W; Masaki, C; Nagahama, M; Ohkuwa, K; Shibuya, H; Sugino, K; Suzuki, A; Uruno, T | 1 |
Fukuta, F; Hashimoto, J; Hashimoto, K; Hiyama, Y; Ichihara, K; Kobayashi, K; Masumori, N; Muranaka, T; Niiyama, Y; Takahashi, S; Yamakage, M | 1 |
Bartlett, CS; Groth, ME; McMillian, WD; Redfern, J; Wasilko, SM | 1 |
Abelleira, M; Castelli, J; Etlin, A; Gerona, S; González, LS; Grecco, G; Harguindeguy, M; Iglesias, C; Leites, A; López, M; Medina, JC; Menéndez, J; Prieto, J; Rando, K; Scalone, P; Valverde, M | 1 |
Hulin, A; Khoudour, N; Legrand, T; Tournier, N; Vodovar, D | 1 |
Buclin, T; Cochet, C; de Valliere, S; Decosterd, L; Gardiol, C; Van Neyghem, N; Voumard, R | 1 |
Bruch, R; Chatelle, C; Dincer, C; Kling, A; Rebmann, B; Schumann, S; Urban, G; Weber, W; Wirth, S | 1 |
Cahan, A; Cohen, MJ; Kleinhendler, E; Moses, AE; Paltiel, O; Strahilevitz, J | 1 |
Adam, T; Bachmann, F; Budde, K; Friedersdorff, F; Liefeldt, L; Slowinski, T; Waiser, J | 1 |
Allegaert, K; Cristea, S; De Cock, P; de Jaeger, A; De Paepe, P; Knibbe, CAJ; Krekels, EHJ | 1 |
Jamieson, C; Jenkins, A; Santillo, M; Shanu, S | 1 |
Doogue, M; Jensen, BP; Mortensen, JS | 1 |
Chen, H; Dai, L; Hou, D; Li, T; Long, X; Sun, C; Wang, Y; Xiong, Z | 1 |
Akita, H; Asukai, K; Fujii, Y; Hara, H; Haraguchi, N; Hasegawa, S; Kanemura, T; Matsuda, C; Mikamori, M; Miyata, H; Mukai, Y; Nishimura, J; Ohue, M; Omori, T; Sakon, M; Shinno, N; Sugase, T; Takahashi, H; Takeoka, T; Wada, H; Yamamoto, M; Yasui, M | 1 |
Bautista, J; Beique, L; Cayen, J; Choi, K; Comeau, JL; Conly, J; Dalton, B; Delport, J; Dhami, R; Embree, J; Émond, Y; Evans, G; Frenette, C; Fryters, S; Happe, J; Katz, K; Kibsey, P; Langley, JM; Lee, BE; Lefebvre, MA; Leis, JA; McGeer, A; McKenna, S; Neville, HL; Pelude, L; Rudnick, W; Science, M; Slayter, K; Suh, KN; Thirion, DJG; Tse-Chang, A; Weiss, K | 1 |
4 review(s) available for piperacillin and cefazolin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[The pathophysiology and treatment of severe intra-abdominal abscess].
Topics: Abdominal Abscess; Cefazolin; Cephalosporins; Enterococcus faecalis; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Intestines; Penicillins; Peritoneal Diseases; Piperacillin | 1996 |
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Ceftazidime; Floxacillin; Humans; Outpatients; Piperacillin; State Medicine; Tazobactam | 2022 |
Preanalytical Stability of Flucloxacillin, Piperacillin, Tazobactam, Meropenem, Cefalexin, Cefazolin, and Ceftazidime in Therapeutic Drug Monitoring: A Structured Review.
Topics: Anti-Bacterial Agents; Cefazolin; Ceftazidime; Cephalexin; Drug Monitoring; Drug Stability; Floxacillin; Humans; Meropenem; Piperacillin; Tazobactam | 2022 |
2 trial(s) available for piperacillin and cefazolin
Article | Year |
---|---|
Piperacillin versus cefazolin given perioperatively to high-risk patients who undergo open cholecystectomy: a double-blind, randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; Cefazolin; Cholecystectomy; Double-Blind Method; Female; Gallbladder; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Postoperative Complications; Premedication; Prospective Studies; Risk Factors; Surgical Wound Infection | 1993 |
Antimicrobial prophylaxis for the prevention of surgical site infection after thyroid and parathyroid surgery: a prospective randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Child; Female; Humans; Male; Middle Aged; Parathyroid Diseases; Piperacillin; Prospective Studies; Surgical Wound Infection; Thyroid Diseases; Urinary Tract Infections; Young Adult | 2015 |
52 other study(ies) available for piperacillin and cefazolin
Article | Year |
---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Identification and characterization of a new metallo-beta-lactamase, IND-5, from a clinical isolate of Chryseobacterium indologenes.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chryseobacterium; Flavobacteriaceae Infections; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.
Topics: Aeromonas; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; France; Integrons; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Substrate Specificity | 2007 |
E240V substitution increases catalytic efficiency toward ceftazidime in a new natural TEM-type extended-spectrum beta-lactamase, TEM-149, from Enterobacter aerogenes and Serratia marcescens clinical isolates.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Catalysis; Ceftazidime; Enterobacter aerogenes; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Sequence Analysis, DNA; Serratia marcescens; Structure-Activity Relationship; Substrate Specificity | 2008 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Carbapenem resistance among Pseudomonas aeruginosa strains from India: evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18).
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Prevalence; Pseudomonas aeruginosa; Ribotyping | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Genetic and biochemical characterization of TRU-1, the endogenous class C beta-lactamase from Aeromonas enteropelogenes.
Topics: Aeromonas; Amino Acid Sequence; Base Sequence; beta-Lactamases; Cloning, Molecular; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Kinetics; Molecular Sequence Data; Phylogeny; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Transformation, Genetic | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Biological Availability; Cefazolin; Drug Therapy, Combination; Escherichia coli Infections; Humans; Infusions, Intravenous; Lactams; Male; Microbial Sensitivity Tests; Peritonitis; Piperacillin; Rats; Rats, Inbred Strains; Serratia Infections | 1992 |
[A case of Garcin's syndrome caused by pachymeningitis secondary to otitis media, responsive to antibiotic therapy].
Topics: Cefazolin; Cranial Nerve Diseases; Drug Therapy, Combination; Dura Mater; Facial Paralysis; Female; Humans; Hypertrophy; Imipenem; Meningitis; Middle Aged; Otitis Media; Piperacillin; Syndrome | 1991 |
Placental transfer of cefazolin and piperacillin in pregnancies remote from term complicated by Rh isoimmunization.
Topics: Blood Transfusion, Intrauterine; Cefazolin; Chorioamnionitis; Female; Humans; Maternal-Fetal Exchange; Piperacillin; Placenta; Pregnancy; Rh Isoimmunization | 1990 |
In vitro activity of amdinocillin in combination with other beta-lactam antibiotics against aminoglycoside-susceptible and resistant gram-negative bacteria.
Topics: Amdinocillin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefoxitin; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Piperacillin; Ticarcillin | 1988 |
Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin.
Topics: Amdinocillin; Ampicillin; Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefoxitin; Drug Combinations; Enterobacteriaceae; Microbial Sensitivity Tests; Piperacillin; Ticarcillin | 1987 |
Pharmacokinetic studies on the concomitant administration of piperacillin and cefazolin, and piperacillin and cefoperazone in rabbits.
Topics: Animals; Cefazolin; Cefoperazone; Drug Interactions; Infusions, Parenteral; Injections, Intravenous; Kinetics; Male; Piperacillin; Rabbits | 1986 |
Antibacterial activity of temocillin.
Topics: Cefazolin; Cefotaxime; Dose-Response Relationship, Drug; Enterobacteriaceae; In Vitro Techniques; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin | 1985 |
Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.
Topics: Amikacin; Bacteria; Carbenicillin; Cefazolin; Cephalosporins; Cephamycins; Culture Media; Humans; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Sepsis; Species Specificity; Ticarcillin; Tobramycin | 1980 |
Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Disease Models, Animal; Escherichia coli Infections; Male; Mice; Peritoneal Diseases; Piperacillin | 1996 |
Biliary complications after orthotopic liver transplantation in rats.
Topics: Animals; Bile Ducts; Biliary Tract Diseases; Cefazolin; Cephalosporins; Enterobacteriaceae Infections; Liver Transplantation; Necrosis; Opportunistic Infections; Penicillins; Piperacillin; Rats | 1999 |
Peritonitis in automated peritoneal dialysis: antibiotic therapy and pharmacokinetics.
Topics: Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Penicillins; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperacillin; Tobramycin | 2001 |
[A questionnaire survey on the theory of postoperative infection prophylaxis in urology].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cefazolin; Cefotiam; Humans; Penicillins; Piperacillin; Postoperative Complications; Surgical Wound Infection; Surveys and Questionnaires; Urology | 2002 |
[A questionnaire survey on the theory of postoperative infection prophylaxis in otorhinolaryngology].
Topics: Antibiotic Prophylaxis; Cefazolin; Cefotiam; Cephalosporins; Drug Utilization; Humans; Otorhinolaryngologic Surgical Procedures; Piperacillin; Surgical Wound Infection; Surveys and Questionnaires | 2003 |
[Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Cefmetazole; Cefotiam; Coagulase; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fosfomycin; Methicillin; Piperacillin; Staphylococcus; Staphylococcus aureus | 2003 |
[Candida parapsilosis endocarditis after prolonged antibiotic therapy].
Topics: Candida; Candidiasis; Cardiac Tamponade; Cefazolin; Disease Susceptibility; Drug Therapy, Combination; Endocarditis; Fatal Outcome; Humans; Ischemia; Leg; Male; Middle Aged; Opportunistic Infections; Penicillanic Acid; Piperacillin; Postoperative Complications; Superinfection; Tazobactam | 2002 |
Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Drug Combinations; Drug Incompatibility; Drug Interactions; Drug Stability; Heparin; Humans; Partial Thromboplastin Time; Piperacillin; Vancomycin | 2005 |
Diaphragm paralysis in children after cardiac surgery.
Topics: Anti-Bacterial Agents; Cardiac Surgical Procedures; Cefazolin; Diaphragm; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Ofloxacin; Paralysis; Phrenic Nerve; Piperacillin; Pneumonia; Postoperative Complications; Risk Factors; Sepsis | 2007 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
Piperacillin/tazobactam-induced seizure rapidly reversed by high flux hemodialysis in a patient on peritoneal dialysis.
Topics: Anti-Bacterial Agents; Brain; Bronchiectasis; Cefazolin; Cefepime; Cephalosporins; Electroencephalography; Epilepsies, Myoclonic; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Molecular Structure; Penicillanic Acid; Penicillin G; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Dialysis; Tomography, X-Ray Computed | 2007 |
Clinical response at Day 3 of therapy and economic outcomes in hospitalized patients with acute bacterial skin and skin structure infection (ABSSSI).
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Cefazolin; Female; Hospitalization; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Skin Diseases, Bacterial; Skin Diseases, Infectious; Sulbactam; Treatment Outcome; Vancomycin | 2013 |
Serum antimicrobial concentrations for surgical antimicrobial prophylaxis in radical nephrectomy and radical prostatectomy.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Cefazolin; Female; Half-Life; Humans; Kidney; Male; Middle Aged; Neoplasms; Nephrectomy; Piperacillin; Prospective Studies; Prostate; Prostatectomy; Surgical Wound Infection; Urologic Surgical Procedures | 2015 |
Surgical Site Infections in Patients With Type 3 Open Fractures: Comparing Antibiotic Prophylaxis With Cefazolin Plus Gentamicin Versus Piperacillin/Tazobactam.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cohort Studies; Drug Combinations; Female; Fractures, Open; Gentamicins; Humans; Longitudinal Studies; Male; Middle Aged; Patient Readmission; Penicillanic Acid; Piperacillin; Prevalence; Retrospective Studies; Risk Factors; Surgical Wound Infection; Survival Rate; Tazobactam; Treatment Outcome; Vermont | 2016 |
Impact of a Multimodal Approach in Prevention of Surgical Site Infection in Hepatic Transplant Recipients.
Topics: Administration, Cutaneous; Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Cefazolin; Chlorhexidine; Drug Administration Schedule; Drug Therapy, Combination; Ether; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Liver Transplantation; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Transplant Recipients | 2016 |
Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Humans; Oxacillin; Piperacillin; Ultraviolet Rays | 2016 |
Antibiotic stability related to temperature variations in elastomeric pumps used for outpatient parenteral antimicrobial therapy (OPAT).
Topics: Anti-Bacterial Agents; Cefazolin; Cefepime; Cephalosporins; Drug Stability; Elastomers; Female; Floxacillin; Healthy Volunteers; Humans; Infusion Pumps; Male; Piperacillin; Polymers; Temperature | 2017 |
Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefuroxime; Drug Monitoring; Female; Humans; Male; Microfluidic Analytical Techniques; Piperacillin; Point-of-Care Testing; Precision Medicine | 2017 |
Empiric antibiotic protocols for cancer patients with neutropenia: a single-center study of treatment efficacy and mortality in patients with bacteremia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Cefazolin; Clinical Protocols; Enterobacteriaceae Infections; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2018 |
Perioperative antibiotic prophylaxis in renal transplantation: a single-center comparison between two regimens and a brief survey among the Eurotransplant renal transplantation centers.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Escherichia coli Infections; Europe; Female; Floxacillin; Humans; Kidney Transplantation; Male; Middle Aged; Perioperative Care; Piperacillin; Postoperative Complications; Retrospective Studies; Sepsis; Sex Factors; Sulbactam; Surgical Wound Infection; Surveys and Questionnaires; Urinary Tract Infections | 2019 |
Estimation of Ontogeny Functions for Renal Transporters Using a Combined Population Pharmacokinetic and Physiology-Based Pharmacokinetic Approach: Application to OAT1,3.
Topics: Adolescent; Amoxicillin; Biological Variation, Population; Cefazolin; Child; Child, Preschool; Clavulanic Acid; Drug Interactions; Glomerular Filtration Rate; Humans; Infant; Infant, Newborn; Kidney; Male; Models, Biological; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Piperacillin; Renal Elimination | 2021 |
Pathogenicity and transcriptome analysis of a strain of Vibrio owensii in Fenneropenaeus merguiensis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Ciprofloxacin; Citrates; Gene Expression Profiling; Immunity, Innate; Lectins, C-Type; Minocycline; Oxacillin; Penaeidae; Phosphatidylinositol 3-Kinases; Piperacillin; Proto-Oncogene Proteins c-akt; Pyruvates; Streptomycin; Transcriptome; Vibrio; Virulence | 2022 |
The utility of bile juice culture analysis for the management of postoperative infection after pancreaticoduodenectomy.
Topics: Anti-Bacterial Agents; Bile; Cefazolin; Drainage; Humans; Pancreaticoduodenectomy; Piperacillin; Postoperative Complications; Preoperative Care; Retrospective Studies; Surgical Wound Infection; Tazobactam | 2023 |
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018.
Topics: Adult; Anti-Infective Agents; Canada; Cefazolin; Ceftriaxone; Child; Cross Infection; Hospitals; Humans; Infant, Newborn; Inpatients; Piperacillin; Tazobactam | 2023 |